Rottapharm of Italy prices IPO
This article was originally published in Scrip
Executive Summary
The Italian pharmaceutical company Rottapharm Madaus is planning an initial public offering (IPO) of its shares later this month on the Italian Stock Exchange which will value the company at between €1.45bn–1.8bn.